The use of monoclonal antibody (Rituximab) in the treatment of type II mixed cryoglobulinemia
Anti-CD20 monoclonal antibody has been successfully used to treat several self-immune diseases. The authors report the case of a 71 year-old female patient under the use of pegylated form of interferon á associated with ribavirin for the treatment of hepatitis C, who, after concluding the therapeuti...
Main Authors: | Thiago Carlos Gonçalves Rego, Celso Mitsushi Massumoto, Rodrigo Siqueira Batista, Larissa Hanauer de Moura, Lygia Maria Costa Soares, Andréia Patrícia Gomes |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
|
Series: | Brazilian Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702007000100038&lng=en&tlng=en |
Similar Items
-
Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren'sdisease
by: V I Vasilyev, et al.
Published: (2004-08-01) -
The beginning of the new era of monoclonal antibodies biosimilars use in oncology:current international guidelines and the results of clinical trial of the first Russian rituximab biosimilar in patients with B-cell non-Hodgkin’s lymphoma
by: K D Kaplanov, et al.
Published: (2014-06-01) -
Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment
by: Letizia Polito, et al.
Published: (2013-10-01) -
Hepatitis C: crioglobulinemia y linfoma no-Hodgkin Hepatitis C: cryoglobulinemia and non-Hodgkin lymphoma
by: M. Romero-Gómez, et al.
Published: (2008-03-01) -
Type I cryoglobulinemic nephritis in a patient of monoclonal gammopathy of renal significance
by: V A Lobo, et al.
Published: (2018-01-01)